Dr. Alhossan is an assistant professor of clinical pharmacy at King Saud University (KSU) and an ambulatory care clinical pharmacist at KSU medical city. He is the director of corporate pharmacy services and the chairman of the department of clinical pharmacy and the director of community pharmacy unit at the College of Pharmacy. Dr. Alhossan received a bachelor of pharmaceutical sciences degree from King Saud University and a doctor of pharmacy degree from MCPHS University, USA. He completed his PGY1 ambulatory care-focused pharmacy residency and at The University of Arizona (UA) Medical Center-El Rio Healthcare, and completed his ambulatory care fellowship program at the Center for Health Outcomes and PharmacoEconomic Research (HOPE) at the College of Pharmacy in The University of Arizona. He also completed a master of public health degree from the School of Public Health, UA. Dr. Alhossan is board certified as Pharmacotherapy Specialist (BCPS) from the board of pharmaceutical specialties (BPS) in the US and director for several committees. Dr. Alhossan’s areas of interest include ambulatory care, community pharmacy, and academia.

Prof. Molokhia obtained his PhD from the University of Michigan, USA 1973. He held academic positions at Universities of Houston, Riyadh and Alexandria and is a current member of the Egyptian National Pharmacology Committee. He advised more than 52 PhD and MS candidates and co-authored more than 158 original manuscripts and presentations to national and international conferences. Between 1996-2004, he was the chairman of the Egyptian National Organization for Drug Control and Research at the Ministry of Health. From 2004 until 2013, he chaired the European Egyptian Pharmaceutical Industries Company, a division of Pharco Pharmaceuticals, Alexandria, Egypt. Between 2007-2013, he chaired the Pharmaceutical Sector of the Pharmaceuticals and Cosmetic Chamber at the Egyptian Industry Union. Prof. Molokhia chaired several conferences organized among NODCAR, the MOH and the WHO. As consultant to the WHO, he presented training and consultations to nine countries in the EMRO region. Prof. Molokhia co-chaired 5 Egyptian-USP Symposia on “Science and Standards”. He acts as observer representing the Egyptian Chamber of Pharmaceuticals with the USP Convention.

Dr. Abdullatif Alokifi is the Director of Strategic Planning and Operation in General Directorate of Quality and Patient Safety at Saudi Ministry of Health. He is the General Secretary of Saudi Pharmaceutical Society. He was the CEO of Aljazeera Hospital. He used to be the Quality Director of Alhammadi Hospital. He was the Assistant Head, Ambulatory Healthcare Center Department at CBAHI. He was the Associate Executive Director for Ancillary Services at King Abdullah Bin Abdulaziz University Hospital (KAAUH) and the Pharmacy Director belong to Princess Nora University (PNU). He was also the Director of Pharmacy and A/Head of Continuous Professional Development at Riyadh Care Hospital (RCH), Riyadh. He is working as Pharmacy Surveyor at Saudi Center for Accreditation of Healthcare Institutions (CBAHI) since 2010. He has activities as a Clinical Associated Professor for training of PharmD students in cooperation with Pharmacy College, King Saud University and as a Clinical Associated Instructor at Riyadh College for Dentistry and Pharmacy for Bachelor and Master Candidates. He has a lot of participations in pharmacy management, medication safety, quality and career development. Dr. Alokifi is distinguished speaker nationally and international. He got many award as best pharmacist and best preceptor from KSU and DUPHAT pharmacy international conference in Dubai. Dr. Alokifi got his bachelor’s degree in pharmacy 2000 from KSU, Pharmacy College and his Master’s Degree 2007 in Management and Hospital Administration. He conducted many projects and improvement initiatives in shape the good pharmacy practice using the current updated quality tools.

Dr.Dr.Abdulmajeed Alzubaidi is an Emarati MD with an undergrad of Medicine and Surgery (MBBS) from Cairo University. He continued to get a graduate education in Cardiology from the University of British Columbia Hospitals on addition to a graduate education in Interventional Cardiology program from University of British Columbia. In 2008, he obtained level 3 accreditation in Cardiac CT Performance and Interpretation from the Society of Cardiovascular Computerized Angiography. Dr.Abdulmajeed had an extensive experience in the medical field as he is a consultant interventional cardiologist in SKMC since 2005. He then became the chair of SEHA physician advisory council on EMR from 2008 to 2012. Moreover, he then was appointed as the Chief Medical Officer in SKMC from 2012 till 2017. From March 2017 he was made to be the Chair of Cardiac Science at SKMC, as will as the Chief Medical officer at Mafraq Hospital since April 2018. Dr.Abdulmajeed has substantial involvement in research, committees, and conferences. Not to mention the lectures and presentation that he gave regionally in through various platforms.

Summary : My long-term research interests focus on the development and improvement of immunotherapeutic strategies, including oncolytic viruses, gene therapy, and immune checkpoint inhibitors, for the treatment of several cancers and diseases. Experience: ● Head of the Science and Technology Unit at Taibah University, (2019 – Present) ● Assistant to the Vice Dean for Graduate Studies and Scientific Research, College of Applied Medical Sciences, Taibah University, (2019 – Present) ● Assistant to the Head of Department of Medical Sciences, College of Applied Medical Sciences, Taibah University, (2019 – Present) ● Harvard Medical School Faculty Member (part-time lecturer), Boston, MA, USA. (2018 – 2019) ● Assistant professor, Taibah University, (2018 – Present) ● Scientific Advisor, VOIRx ltd, Riyadh, Saudi Arabia. (2018 – Present)

-

Dr. Aldemerdash is an assistant professor in the college of pharmacy, King Saud University (KSU), Saudi Arabia and cardiovascular pharmacotherapy pharmacy specialist in King Saud University Medical City (KSUMC) where he provides comprehensive services to the cardiac ICU teams, heart failure service and anticoagulation clinics. He also serves as the director of the pharmacy practice residency program (PGY1), Cardiology Residency Program (PGY2) at KSUMC and Pharmacy fellowship programs. Dr. Aldemerdash received a bachelor’s degree in pharmaceutical sciences from KSU and PharmD degree from MCPHS University, MA, USA. He completed his PGY1 and PGY2-Cardiovascular pharmacotherapy residencies at Brigham and Women’s Hospital, MA, USA. In addition, he completed cardiovascular pharmacotherapy fellowship in the University of North Carolina. He currently services as a board member of the Saudi Society of Clinical Pharmacy.

I am a pharmacist since 1999 graduated from University of Sunderland in UK. I have been working as a pharmacist in Farwaniya general hospital in Kuwait where, I rotated to cover all units in the pharmacy department. In 2015 graduated from UCL to hold a degree in MSc programme in Clinical Pharmacy. Then, I have started a clinical pharmacy unit in Farwaniya hospital. I have been helping Kuwait university as a preceptor to train PharmD students when they have their placement in Farwaniya hospital. Graduated in 2019 from an MSc programme in Diabetes from University of Dundee in UK.

Dr. Ahmed Alaofi joined Pharmaceutical Chemistry Department, University of Kansas, USA in 2010. He worked as a graduate research assistant under support of NIH Biotechnology program in which he earned his MSc. degree in 2012 and his PhD in 2016 from the same department at the University of Kansas, Lawrence, KS, USA. At that time Dr. Ahmed worked on developing and designing biological and synthetic peptides to enhance treatment of brain diseases. In 2016 he was appointed as assistant professor of Pharmaceutical Biotechnology at Pharmaceutics Department, College of Pharmacy, King Saud University. Currently, his research interests focus on studying the effect of conformations and dynamic of therapeutic proteins, monoclonal antibodies, and potential viral particles to their activity, affinity and stability using dynamic techniques such as NMR, computer programs (MD Simulations), and others. In addition, his research area includes developing and designing synthetic peptides and therapeutic proteins as well as physical and chemical characterization studies for potential proteins. Dr. Ahmed is a visiting scholar for Molecular Bioscience Department at the University of Kansas, Lawrence, KS USA since 2017. Dr. Ahmed is a joint member at the National Biotechnology Center at King Abdulaziz City for Science and Technology (KACST) in infectious diseases program.

Ahmed Hassan Bu Shafia is a pharmacy graduate who received his Pharm.D degree from the College of Clinical Pharmacy at King Faisal University in Al-Ahsa, Saudi Arabia in 2010. And his Master's degree in Pharmacology and Toxicology from The Arnold & Marie Schwartz College of Pharmacy and Health Sciences at Long Island University in Brooklyn, New York, the United States of America in 2015. Ahmed worked for a year as a hospital pharmacist at King Fahad Hospital in Al-Hofuf, Al-Ahsa. He is currently working as a pharmacy director, pharmacy quality coordinator, medication safety officer, and medication counseling clinic provider at Al-Omran General Hospital in Al-Ahsa. Ahmed is also the Pharmacy Therapeutics Committee Coordinator and involved as a member in a number of committees such as the Infection Control, Quality, and CPR Committees in the later hospital. And being a member of Rho Chi Society since 2014. His interest is in neuropharmacology especially in the field of neurodegenerative diseases as the Alzheimer's disease.

Professional: Professor, Temple University School of Pharmacy, 2000- Director, Center for Pharmaceutical Health Services Research, 2000- Director, Outcomes Research and Management, Merck & Co., 1997-2000 VP, Pharmacy Managed Care First Health, 1994-1997 Dean, Philadelphia College of Pharmacy, 1990-1994 Professor, Director of Graduate Studies, University of Minnesota, 1973-1990 Education: B.S. Pharmacy, University of Buffalo M.B.A., State University of New York at Buffalo Ph.D., Purdue University, W. Lafayette, IN PostDoc Fellow, University of London, St. Thomas’ Medical School, UK Activities: Author of more than 400 journal articles Author of more than 30 book chapters Author of 29 books Supervised 70 Ph.D. students Supervised 104 MS students Invited lectures in 52 countries Consulting activities in 31 countries Manuscript reviewer: 13 journals Editorial Board Member: 2 journals Editor: one journal Areas of Expertise: Pharmaco-economics, outcomes research, managed care pharmacy, pharmaceutical health services research, international health policy.

-

Ali Abdul Kareem Al Obaidli is the Group Chief Academic Affairs Officer at the Abu Dhabi Health Services Co. (SEHA) and a Consultant Nephrologist & Transplant Physician at the Sheikh Khalifa Medical City (SKMC) & the Imperial College London Diabetes Centre in Abu Dhabi, United Arab Emirates. Dr. Al Obaidli graduated from The Royal College of Surgeons in Ireland (RCSI) in 1997. He got certified at the American Board of Internal Medicine (ABIM) in 2002 and Royal College of Physicians and Surgeons of Canada for Internal Medicine in 2003. He then got American-board certified for Nephrology in 2004 and received certification for Nephrology at the Royal College of Physicians and Surgeons of Canada in the same year. He is also a Board Member of the National Rehabilitation Center in Abu Dhabi.

Dr. Almohanad possess expertise in translational research, specifically, biologics development for cancer immunotherapy with extensive experience in animal modeling to study and evaluate preclinical efficacy as well as immunological responses to novel anticancer agents. He has gained extensive experience in oncolytic virus engineering as well as viral-host interactions.Has a great knowledge in the understating of the conduction/design of the clinical trials as well as the pre-clinical and the non-clinical evaluation of potential drug(s). My research program focuses on development of next- generation oncolytic cancer vaccines to effectively treat cancers.

-

-

Community pharmacist in Spain. President of ASPROFA (Pharmacy Professionals Association in Spain). Pharmacist of the year in Spain in 2017. Speaker in more than 100 conferences, courses and congress national and international. Council member of the Balearic Society of Cardiovascular Risk and Hypertension. Council member of Cooperativa d'Apotecaris (medication distribution warehouse). Member of FIP (International Pharmacy Federation), and poster presenter at the 3 FIP congress in Glasgow, Dusseldorf and Abu Dhabi.

Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has forty years of professional experience in preventing drug use problems and substance misuse. Dr. Bleidt served fourteen years as Chair of the Program Committee for the Alcohol, Tobacco, and Other Drugs Section of the American Public Health Association and five years for the Pharmacy Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the Unites States Pharmacopoeia Convention since 1985. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001);and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida.

Ms. Christina Landgren is the compliance director and business partner for AstraZeneca, responsible for the GCC and NE clusters. She received her BScN degree from the University of Lund, Sweden and various certifications in clinical trials management. Ms. Landgren has extensive experience from the healthcare field having held various positions in 6 countries across 4 continents. She started her career in nephrology nursing and later moved into holding various positions in clinical project management for Gambro Healthcare in Sweden, Australia, USA and Turkey. In 2003 Ms. Landgren joined AstraZeneca in the UAE where she held the positions of clinical project manager, medical manager and market access manager prior to taking on the compliance director role in 2011. Ms. Landgren has a passion for patients and ethical business and holds the AstraZeneca values of “Putting patients first” and “We do the right thing” at the forefront in her work.

-

-

-

He is a Professor of Governance Practices, the President of Value Institution for postgraduate education, a Visiting Professor and Thesis advisor at various academic institutions and a faculty member of governance workgroup at Cambridge Worldwide Academy; U.K., Also, he worked for nine years as part-time consultant at WHO-EMRO. Dr Emad is also a founding member, vice president and secretary general of Egyptian Healthcare Society (E.H.S.). Wherein, he has extensively contributed to both scientific and entrepreneurial fields of health care and pharmacy practices governance, academic research and education, health-economics, and pharmaceutical diligence circles of pharmacoepidemiology, pharmacovigilance and medicines regulations. Dr Emad had BSc of Pharmaceutical Sciences; Master of Business Administration; A.U.C., Doctor of Pharmacy; Saskatchewan, Diploma in International-Economics; Cambridge, and PhD in Industrial Management; Aston University. Further, over the last fifteen years, he has been focusing on academic, educational and clinical governance practices domains. As a governance adviser, Dr Emad has frequently conducted in-house governance counsels and endorsements for both public and corporate organisations; directed several real-world governance oversight operations and institutional integration processes whereby, he has enacted governance initiatives in diverse contexts of postgraduate education, health and pharmacy, health care delivery, health system restructuring and social responsibility activities; and adopted an assortment of practical tools, programs, toolkits and checklists for bylaws development and legislative compliance, governance assessment and enforcement as well as stakeholders and public administration. And, as an international speaker and panellist Dr Emad frequently delivered speeches on healthcare and pharmacy governance related conferences and workshops. He authored and published in different international journals a number of books, articles, reports and curricula addressing governance theory, multi-aspect foundations of research, vocational education and health care system.

• Bachelor Degree in Pharmacy. Dubai Pharmacy College, United Arab Emirates, July 2009. CGPA 3.85 • Associate Degree in Pharmacy. College of Health sciences Ministry of Health, Bahrain, January 2006. CGPA 3.80 Salmaniya Medical Complex • Position: pharmacist, April 2010. • Head of Preparation and Inventory control since 2017 • Head of Auditing and inspections Committee. • Member of medication safety committee. • Member of Risk Management team. • Member of Bahrain Pharmacists Society. • Aramco Hospital, Saudi Arabia. On Job Training as Sterile Compounding Preparation, 2013. • Compounding Sterile preparation and Aseptic technique USP <797> Training program. Jeddah 21-27 April 2017 • JALPHAR, UAE, Ras Al Khaima, Position: On Job Training, One Month • Delmon private Pharmacy Position: On Job Training, Six Months

Born in Como (Italy), the 9th of December 1974, Fabio Sonvico graduated at the University of Pavia (Italy) in Chemistry and Pharmaceutical Technologies in 1999. His Master Thesis was carried out in collaboration with Bayer Italia on "Near Infra Red Spectroscopy application to QA of solid dosage forms". In 2004 he received his Ph.D. form University of Parma(Italy) and University of Paris XI (France). His research project focused on "Functionalised metal nanoparticles for the treatment of solid tumors” and had as supervisors Prof. Paolo Colombo and Prof. Patrick Couvreur. During his Ph.D. he obtained a a grant from the French Association for the Research on Cancer (AIRC) to support his research. In 2005 he was researcher of the Italian Research Council (CNR) based at the National Institute of the Physics of the Matter (INFM, Parma). From the end 2005 till 2012 he was Assistant Professor at the Pharmaceutical Department of the University of Parma. From 2007 till 2012 he was Invited Professor at the University of Lyon (France) and the University of Strasbourg (France) delivering some lectures related to Pharmaceutical Nanotechnologies. In 2010 and 2011 he obtained the Brain Gain Grant from Malaysia Government and spent two months at the National Institute for Pharmaceuticals and Nutraceuticals in Penang (Malaysia). From 2012 to 2014 he was Senior Lecturer at the Graduate School of Health of the University of Technology Sydney (Australia). Since January 2015 he is Associate Professor at the Department of Pharmacy of the University of Parma following several research projects on drug administration by nasal and pulmonary routes and innovative delivery systems for the treatment of lung tumors. He is in charge of the subjects of Pharmaceutics, Pharmaceutical Regulations and Manufacturing of Medicinal Products for the courses of Pharmacy and Chemistry and Pharmaceutical Technologies at the Department of Food and Drug of the University of Parma. He authored more than 80 paper on international scientific journals, 6 book chapters and 6 patents on novel dosage forms.

Fatemah Alherz is an assistant professor of pharmacology at Almaarefa University, Riyadh, Saudi Arabia since August 2019. She holds a Ph.D. in Experimental Therapeutics from Toledo University, Toledo, USA and a B.S. in pharmaceutical sciences from King Saud University. She is also a member of the research and quality committee of Almaarefa University. She worked at King Saud University as a postdoctoral researcher for eight months. She published several papers in genetic polymorphisms of sulfotransferase enzymes. Her research interest is studying the impact of single nucleotide genetic polymorphism on the enzymatic activity of sulfotransferase enzymes.

Qualifications - Pharmacological preparations characteristic in the skin - General medical preparations - Dispensing Education: Bachelor Degree in Pharmacy - Sindh University 2003 Master Degree - Parmaceutical Sciences - Suez Canal University 2017

-

Mr Haitham ElFadally is currently leading integrity and compliance in Novartis Gulf. Mr Haitham has prior experience of working in different functions within pharmaceutical industry including; Sales, marketing, key account management, and medical affairs, supporting various therapeutic areas (Neuroscience, ophthalmology, cardio metabolic..). He worked in different multinational pharmaceutical companies including BMS, Merck, Astra Zeneca previous to Novartis in various markets across Middle East (Egypt, Kuwait, UAE)

-

HAMED AL MAHRIZI is a senior supply chain management, specialized pharmacist graduated from the Oman Assistant, Pharmacy Institute in Sultanate of Oman in 1999 with a Diploma in Pharmacy. Then he continued his further study to graduate from the University of Strathclyde (Scotland, UK) in 2007 with Master of Sciences of Pharmacy (Mpharm). He received his Master of Science degree (MSc) in Supply Chain and Operation Management in 2011 from the University of Strathclyde (Scotland, UK). Hamed joined Directorate General of Medical Supplies (DGMS) in 1999 and worked in different positions which helped him to gain extensive experience in supply chain management. Currently he is working as Assistant Director of Drug Store at Directorate General of Medical Supplies. He is very passionate about innovation and technology solutions, hence he led various information technology improvement projects within DGMS and he was chosen to lead the project of implementation of GS1 standards within the Pharmaceutical Supply Chain.

-

Hossam Magdy, a Market Access Executive with over 15years of experiences in the Pharmaceutical field. Hossam holds a bachelor’s degree in Pharmacy. He worked in several leading Pharmaceutical companies. Throughout his work tenure, he has been focusing on Market Access area wherein he developed strategic plans, market access solutions, policy shaping and pricing models. His immense efforts helped contribute to patients’ lives significantly, through developing diverse patients’ programs; one of which was the first Oncology patient support program in the Gulf region, which was recognized by the company and awarded globally. Hossam currently occupies the role of Market Access director at Ipsen Pharma looking after Middle East, Turkey & Africa region.

Huda Al Harthi, is a senior specialized pharmacist at Khoula Hospital, Oman. Join ministry of health in 1996. She practices clinical pharmacy in orthopaedic surgery for the last 14 years. Currently she is head of clinical pharmacy department in Khoula Hospital. She earned her M.Pharm from Liverpool John Moores University in Liverpool, UK. Later she did her MSc in Clinical Pharmacy in Strathclyde University in Glasgow, UK. Her pharmacy experience includes teaching staff and students, and clinical pharmacy in orthopedic surgery departments. She participated actively in symposium, conferences and workshop as speaker. . Huda served as a member in the National Antimicrobial Sub-Committee in MOH. Plus she is coordinator of drug and therapeutic committee in Khoula Hospital. Huda has being involved in developing many guidelines and policies and procedures in her place of work; for example National Surgical Antimicrobial Prophylaxis Guideline. She is being awarded as best head in 2014 for her outstanding practice and leadership in clinical pharmacy department.

Hussain Bakhsh, PharmD, BCPS Dr. Hussain Bakhsh, Pharm.D., BCPS, is the director of the pharmaceutical services and assistant professor at The Faculty of Pharmacy, King Abdulaziz University Hospital. Dr. Bakhsh earned his Doctor of Pharmacy degree from King Abdulaziz University after which time he completed Pharmacy Practice Residency and Emergency Medicine Specialty Residency training at The University of Arizona. Dr. Bakhsh completed a Postdoctoral Fellowship at The University of Arizona. His area of research includes: emergency medicine and toxicology. Dr. Bakhsh is a Board-Certified Pharmacotherapy Specialist. He is an active member of the American Society of Health-System Pharmacist (ASHP) and the American College of Clinical Pharmacy (ACCP).

-

Dr. Ibrahim Al-Khars is the Co-Founder & Chief Executive Officer of Afaq Alwataniyah Company and the Managing Director/Senior Consultant for People & Business Development Center, Saudi Arabia. Dr. Al-Khars has a Master in Applied Business Research from Swiss Business School, Switzerland; a Master in Business Administration specialized in International Business from the University of Florida, USA and a special diploma degree in new venture creation from the same university. He received a Bachelor degree in Pharmaceutical Science from King Saud University, Riyadh, Saudi Arabia with honor and Master Degree in Clinical Pharmacy from the same university. His academic history includes a Specialty Residency in Pharmacy Practice Management at Detroit Receiving Hospital and Wayne State University, Detroit, Michigan, USA. His research interests include health care quality improvement, health care reform, the economic evaluation of treatment strategies, health care educational system and technologies, and pharmacy practice management. In addition to his teaching and management activities, Dr. Al-Khars has conducted many presentations, executive seminars and management development programs in different countries including Saudi Arabia, USA, Germany, Malaysia, Lebanon, Oman, Egypt, and United Arab Emirates.

He got his bachelor degree in Pharmaceutical Sciences from College of Pharmacy in King Saud University in 2002, and his Master Degree in Health and Hospital Administration from College of Business Administration in King Saud University in 2010. He starts his career as a Pharmacist at King Abdulaziz Medical City at Ministry of National Guard for a short period, then he joint Alnakheel Medical Center in Ministry of Defence. During 18 years in Alnakheel Medical Center, he held many positions in Pharmacy as Inventory Control Supervisor and Pharmacy Supervisor. After he get his Master degree in Health and Hospital Administration in 2010, he promoted to be the Assistant Director of Alnakheel Medical Center tell today. Beside his position, he held other positions. He was the supervisor for Medical Record Department, Nursing Department, and Call-Center Department. He was a Project Manager in Medical Supply Department for a period of time. He participated with the Saudi Pharmaceutical Society as the Editor of Alsaydali Magazine in 2007, and as the president of Saudi Hospital Pharmacy Club in the period (2008-2011).

Isra Al Lawati earned her postgraduate degree in MSc Clinical Pharmacy Service Development at the Robert Gordon University in Aberdeen, United Kingdom in January 2017. She earned her undergraduate degree (Bachelor) in pharmacy at Oman Medical College, Muscat in February 2011. In 2011 she joined the department of pharmacy at Al Masarra Hospital and worked as an in-charge of in-patient pharmacy for 2 years. From 2017 up to now, she is working as Clinical Pharmacist specialist in the psychiatric field, mainly responsible for reviewing patients admitted in the hospital by reviewing their medications and identifying related problems, attending major rounds, applying medicine reconciliation process, providing counseling sessions and applying poly-pharmacy service in the department. She has made numerous presentations to other healthcare professional at hospital level and national level focusing in Pharmaceutical care. Aside from Isra's clinical experience in the pharmaceutical care inside the pharmacy department, she is the leader of the patient safety friendly hospital program of the pharmacy theme in Al Masarra Hospital and member of Smart pharmacy program as smart pharmacist which had been applied in Oman since 2017. She is the leader of poly-pharmacy service of the hospital and had given poster presentation in the first international patient safety day in September 2019. Moreover, she is a member of the local guidelines committee in Al Masarra Hospital who are responsible for developing internal policies and guidelines for the hospital sector. And a member of the research committee in the Hospital who are responsible for conducting researches and studies related to the services provided in the hospital.

Janet P. Engle is the Executive Director of the Accreditation Council for Pharmacy Education (ACPE). She is past president of the American Pharmacists Association (APhA), the national professional society of pharmacists with over 60,000 members. She has served as a voting member of the FDA Nonprescription Drug Advisory Committee and continues as a Special Government Employee Consultant to FDA. Dr. Engle is a past member of the Board of Directors of the Board of Pharmacy Specialties. Dr. Engle was elected as a Distinguished Practitioner in the National Academies of Practice in Pharmacy. Dr. Engle has also been named a Fellow of the APhA Academy of Pharmacy Practice and Management and a Fellow of the American College of Clinical Pharmacy. She also has received the APhA Distinguished Achievement Award for Clinical/Pharmacotherapeutic Practice. Dr. Engle is an internationally recognized expert on the topics of nonprescription medicines, pharmacy education, and leadership and is very active in international pharmacy. She has served as Chair of the ACPE International Commission and is serving a third term as overseas expert of the Post Graduate Allied Health Institute Board at Singapore General Hospital. Dr. Engle has worked with National Taiwan University and was a guest professor at Harbin Medical University in China. She worked with the Pharmacy Council of Thailand and received an honorary PhD in Pharmaceutical Sciences from Khon Kaen University in Thailand. She has served as a consultant to the Western Pacific Region of the World Health Organization. She has practiced pharmacy in community, hospital, long-term care and pharmacy-directed ambulatory clinic settings.

-

John Papastergiou graduated from the Leslie Dan Faculty of Pharmacy, University of Toronto in 2002. After graduation he was employed as a staff pharmacist at Sunnybrook Health Sciences Center. In 2005, John joined Shoppers Drug Mart and acquired his first store at Pape and Danforth. He now owns and operates four locations in downtown Toronto. In 2014, John received an appointment as an adjunct assistant professor at the School of Pharmacy, University of Waterloo. In 2016, he was cross appointed at the Leslie Dan Faculty of Pharmacy, University of Toronto. In addition to managing a large business, John employs his unique background in clinical research to explore an expanded role for the community pharmacist. John strongly believes that the accessibility of the community pharmacist places them in a unique position to actively screen and monitor patients for various chronic diseases. Most recently, he implemented one of the first frontline community pharmacist-directed pharmacogenomics clinics in Canada. His work in this area won first prize at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Buenos Aires, Argentina. John can be heard regularly on the Libby Fights Back Show on AM740 Zoomer Radio and on his top-rated podcast The Pharmacists Are In. In 2012, John was named the Shoppers Drug Mart Associate of the Year. In 2014, he received the OPA Mentorship Award and was named CPhA Canadian Pharmacist of the Year. In 2016, he was the recipient of the OPA Voice of the Profession Award and was awarded the Pharmacy Practice Commitment to Care Award for Overall Patient Care. In 2019, John was named by the International Forum on Advancement in Healthcare as one of the top 100 healthcare leaders globally. He was also presented with the OPA Award for Excellence in Research and Academia.

Dr. Joseph Saba is Co-Founder and Chief Executive Officer of Axios International. Under his leadership, the company has launched a number of successful drug access programs and developed innovative models for market access and healthcare systems strengthening. Dr. Saba is a French Lebanese medical doctor specialized in infectious disease, health management and statistics. Throughout his career, he has led numerous discussions with pharmaceutical companies, governments and other key players across the healthcare community to drive access to innovative medications in developing countries and emerging markets. In this context, he is known internationally for his expertise in the prevention of mother-to-child transmission of HIV and for establishing the first HIV/AIDS antiretroviral drug access programs in Chile, Côte d’Ivoire, Uganda and Vietnam through the UNAIDS HIV Drug Access Initiative. In 1993, Dr. Saba joined the World Health Organization (WHO) as the WHO Focal Point for the National Plan for HIV Vaccine Development, and from 1994-1995, he worked with the Global Program on AIDS in the WHO Department of Clinical Research and Drug Development. Following his time at WHO, he worked with the Joint United Nations Program on HIV/AIDS in the Department of Policy, Strategy and Research, where he coordinated the PETRA study – a multi-centre clinical trial on prevention of mother-to-child transmission of HIV/AIDS in three countries in Africa. Dr. Saba has conducted numerous fieldworks and led various field teams in global health research projects, including a mother-to-child transmission prevention project in Tanzania, South Africa and Uganda, a female condom program in Thailand, and an epidemiologic survey on HIV patients in Rwanda. He completed his medical degree, along with a certificate of Medical Statistics, at the University Paris VI (France). Dr. Saba is also a graduate of St. Joseph University (Beirut, Lebanon) and holds a Master of Communications and Medical Management (MSc) from the Superior Business School (Paris, France). Of Lebanese and French descent, he is fluent in Arabic, French and English. Dr. Saba has been featured in the Pharmaceutical Executive, Reuters, Wall Street Journal, International Herald Tribune and Newsweek, among others.

Joseph A. Zorek, PharmD, BCGP, joined The University of Texas Health Science Center at San Antonio in 2019 as Director of their Quality Enhancement Plan, "Linking Interprofessional Networks for Collaboration," and Associate Professor with Tenure in the School of Nursing. He is a board certified geriatric pharmacist whose practice interests include incorporation of pharmacists into interprofessional teams and mitigation of medication-related risks in older adults through interprofessional practice. Joe previously served as Director of Interprofessional Education (IPE) and Associate Professor at the University of Wisconsin-Madison School of Pharmacy, where he taught courses on pharmacy practice and geriatric pharmacy. His analyses of IPE accreditation standards, first published in the Journal of Interprofessional Care and later updated for invited presentations, including at the National Academy of Medicine, highlighted opportunities to utilize accreditation processes to advance IPE throughout the health professions. Joe was awarded a grant to represent the National Center for Interprofessional Practice and Education on a collaborative project with the Health Professions Accreditors Collaborative. The product of this work, "Guidance on Developing Quality Interprofessional Education for the Health Professions," was endorsed by 24 accrediting bodies in the US and released to the public in February 2019.

Joshua Kriesel earned his Ph.D. in Chemistry from the University of California at Berkeley. Dr. Kriesel is a named inventor on over 35 patents, as well as an author of over 10 peer reviewed scholarly articles. His professional focus has been on the development, manufacture, regulatory approval, and commercialization of drug-device combination products for applications in the infusion of parenteral medicines.

Kais is a consultant, coach and facilitator with 21 years of experience in the Learning & Development and luxury retail industries. Drawing on his involvement in leading projects worldwide, he uses his experience in coaching, retail, media and entrepreneurship to develop powerful programs that help companies and individuals achieve actionable growth. Kais engages his audiences both emotionally and intellectually through presenting live experiences backed with strong visual illustrations and heartfelt stories. He has trained thousands of people across 97 nationalities in 25 countries and many of the fortune 500 companies.

Dr. Khalefa Al Thiab is a consultant clinical pharmacist specialized in Solid Organ Transplantation. Dr. Al Thiab began his career in pharmacy field as a technician pharmacist after having a diploma in pharmacy from the health institute, Riyadh. He received the Bachelor of Science degree in Pharmacy from the college of pharmacy at King Saudi university. After practicing as a hospital pharmacist at King Abdulaziz Medical City Central region (KAMC-CR), he completed the three years Saudi certificate in clinical pharmacy program under the umbrella of the Saudi Commission of Health Specialties. Currently he is covering solid organ transplant & hepatology wards at KAMC-CR, and he has a joint faculty appointment with the King Saud bin Abdulaziz University for Health Sciences, College of Pharmacy.

Khalid Eljaaly, Pharm.D., CAPPS, MS, BCPS, is an assistant professor and infectious disease in faculty of pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia, and an honorary fellow in the University of Arizona, Tucson, AZ, USA. He graduated with a PharmD degree from King Abdulaziz University. He completed his PGY1 pharmacy practice residency at SEMC, a Tuft-University affiliated hospital and his PGY2 infectious disease pharmacy residency at BIDMC, a Harvard Medical School-affiliated hospital in Boston, MA, USA. Then, he completed both infectious disease/antibiotic stewardship pharmacy fellowship and Master of Science in clinical translational sciences at University of Arizona. He is a member of the social media committees of both the Society of Infectious Diseases Pharmacists (SIDP) and the Infectious Diseases Practice and Research Network of the American College of Clinical Pharmacy, and a member of the editorial advisory board of Contagion®. He received several prestigious international awards and published in several top-ranked journals.

Khalid Al-Farsi, male, MSc Supply chain and operation, Master in Pharmacy, graduated from the University of Strathclyde, Glasgow UK. At present, I am working as a Section Head of Central Vaccine Stores in the Department of Medical stores at the Directorate General of Medical supplies, Ministry of Health, Oman. Since 2005, WHO certified as a trainer for WHO Global Training Network on Vaccine Management Course conducted by WHO. Performed as Temporary Advisor/facilitator for WHO, assignment of Vaccine management. From 1994 - 2019, worked in central vaccine store, highlights of activities; As an in charge of vaccine management, cold chain and vaccine logistics the incumbent responsible for planning, implementing, and monitoring the program related to vaccine management, vaccine transportation, selection of cold chain equipment, estimation of supply requirements and will support the health institution in the region to improve their vaccine management system.

Dr. Khalid Al Midfa is the Chairman of Sharjah Media City (Shams) in the United Arab Emirates (UAE). Under his leadership, Shams has become the fastest growing media free zone in the UAE. Dr. Al Midfa’s efforts are focused on making Sharjah a world-class media hub for innovative facilities and services. Prior to Shams, Dr. Al Midfa led the modernization and innovative transformation of the Sharjah Media Corporation, a government organization dedicated to developing the media industry in the Emirate of Sharjah, as General Manager. During his 5-year tenure, he headed the creation of the first infrastructure within the emirate for broadcasting through a terrestrial rather than satellite signal, drastically improving the accessibility of all 3 local TV stations. With a passion towards community health, he has launched and supported several holistic health initiatives, and has always taken up influential roles within the local community, such as co-founder of the Sharjah Tatweer Forum, one of most successful leadership programs across the UAE, and as a former member of the Sharjah Emirate Consultative Council for four years. He has also worked as Assistant Professor in Telecommunications Engineering in Khalifa University. Dr. Al Midfa has a deep interest in innovation and END technology, and as such, he has obtained a PhD in Telecommunications Engineering and a master’s degree in Communication Systems and Signal Processing from the University of Bristol in the United Kingdom. He obtained his bachelor’s degree in Telecommunications Engineering from Khalifa University in the UAE.

Kylee is the Lead Pharmacist for Education and Services at the Society of Hospital Pharmacists (SHPA), a position she has held for seven years. Within her role, she is responsible for the development and provision of educational offerings for pharmacists and pharmacy technicians across Australia. Previous to her current position, Kylee worked as a clinical educator and oncology pharmacist in hospitals in New Zealand, the United Kingdom and Australia. Her interests include the development of pharmacists through the use of effective feedback and the integration of novel technologies into pharmacist education.

Director pf the regional poison control center, Eastern Region, MOH, KSA Chief of Eastern Provence Pharmacist Club (EPPC), Saudi Pharmaceutical Society SPS since 2018 PharmD, MSc Toxicology & Forensic Sciences. PhD in Quality Management, Certified Project Manager (PME), Trainor of Trainers (TOT), KPI Diploma. Consultant at WHO in Lead (Pb) poisoning prevention and management guidelines chapter since 2011 & at National Committee of Narcotic Control (NCNC) since 2009. Published more than 25 research articles and awarded the best research award on the year 2016 from the international journal of Pharmacology & Toxicology and from the 8th world congress on Toxicology & Pharmacology held in Dubai during 2017. Member in many national & International Societies Awarded the governmental e-services best prize for the ELECTRONIC ACHEVEMENT on 2010 from YESSER an e-government Program & the best electronic prize in health care sector all over KSA from WORLD SUMMIT AWARD (WSA2018)

Mahmoud Ghazal has more than 17 years’ experience at P&G working on its prestige brands such as Dolce & Gabbana, Gucci and Boss as well as working as insight leader on brands such as Olay, Oral B and Crest.

Dr. Maitham A. Khajah received his degree in Pharmacy from Faculty of Pharmacy, Kuwait University, in 2003 and obtained his PhD degree in December 2009 from the University of Calgary, Canada (Gastrointestinal Science and Immunology). Since January 2010 he has been assistant professor in Kuwait University, Faculty of Pharmacy, Department of Pharmacology and Therapeutics. His research interest are molecular targets for the treatment of inflammatory bowel disease (IBD) and the mechanisms responsible for immune cell chemotaxis. He cosupervised many students for the MSc Molecular Biology Program, College of Graduate Studies, Kuwait University. Ever since joining Kuwait University in 2010, he got various grants as PI and Co-I. He was awarded the Best Young Researcher Award by Kuwait University, Research Sector, for the Year 2013–2014. He was a member in the organizing committee for three conferences organized by Kuwait University, Faculty of Pharmacy, as cochair and a member in the scientific committee (the 3rd, 4th, and 5th Kuwait International Pharmacy Conference).

-

Dr. Bashihab is a consultant Clinical Pharmacist at Security Forces Hospital Program–Riyadh (SFH-P). She is the Co-chairman of Guidelines and Protocol Committee, and a member in many committees in her institute. Dr. Bashihab recently completed the certification as a new Professional Medication Safety Officer, and are entitled to the CMSO Credential. Dr. Manal received a bachelor pharmaceutical sciences degree from King Saud University, KSA. She obtained the Saudi Specialty Certificate in Clinical Pharmacy Practice (PGY1) in 2008 and she practiced as a pediatric clinical pharmacist until 2012. Then, she continued to obtain a certificate of the Saudi board of Health specialties in Nephrology Pharmacotherapy in 2015 and she used to work as a nephrology clinical pharmacist. Dr. Bashihab previous experience has equipped her to hold the position of an acting supervisor of IV Pharmacy (2009-2010) then promoted as supervisor of IV-Room on 2010 -2012, and finally as the acute care clinical coordinator on 2012-2017. Currently, she has been appointed to fill a responsible position of a regional Representative of the Saudi-FDA Pharmacovigilance office, and a Liaison Safety officer. She established many projects in her institute and delivered many presentations over the years nationally and internationally. Ultimately, Dr. Bashihab is the co-author with Dr. Al-Obaida in an educational book under title of الموسوعة التثقيفية الدوائية, sponsored by Saudi pharmaceutical society.

I am a Quality Director with over 20 years of diversified experiences in Quality Management, Supplier Quality, Manufacturing and Distribution within the multinational Medical Device and Pharmaceutical industries in the United States, Gulf and China. I have developed an extensive experience and knowledge in the implementation of a robust Quality Management Systems in accordance to USFDA 21 CFR 210,211, Health Canada Drug HPFBI-GMP/GUI-0001, Medical Device regulations 21 CFR 820, Medical Device Directive, ISO 9001: 2015 &13485:2016, GLP 17025 and GDP/GSP. I have achieved a track record of outstanding inspection results from USFDA and ISO 13485 for Medical Device and pharmaceutical sites in the United States. My intensive experience enabled me to utilize effectively risk-based management skills for manufacturing, supplier control and distribution network to ensure product quality and business sustainment. I have also developed technical skills in managing testing laboratories, process validations/ process control in compliance with the aforementioned regulations. My acquired skills were deployed effectively in leading/ engaging in new products launches, technology transfer and procurement projects transition to outsourcing operations in the USA, GHC region and China with a track record for remaining within the project timelines/ cost. Further, I was in charge of deploying QMS for business partners and new acquisitions to ensure compliance with USFDA regulations and enhance operation’s output. This was achieved by using practical knowledge and expertise to integrate lean manufacturing principles (utilizing kaizen tools) within a regulated environment, assuring Quality System compliance and harmonization, reducing product defect rate and executing identified projects to achieve product cost avoidance and operational excellence.

Dr. Michael Katz is a Professor in the College of Pharmacy’s Department of Pharmacy Practice and Science, Director of Residency Programs and Director of International Programs. He received his Doctor of Pharmacy degree from the University of Kentucky and completed his residency at the University of Kentucky Medical Center in 1979. He is the Residency Program Director for the PGY2 Internal Medicine program at the University of Arizona College of Pharmacy/Banner – University Medical Center Tucson.

-

-

Tohami is #1 international bestselling author, world's leading entrepreneurship & small business expert, and creator of Passion To Profit® Passion To Profit is the world's EASIEST entrepreneurship program specifically designed to help unfulfilled employees with 5-10 years of experience start a successful passion-based business! Tohami is a mentor and program manager at the Founder Institute (FI). FI is the world's largest idea-stage accelerator. It maintains chapters in over 180 cities and more than 65 different nations across the globe. He is also a member of the AmCham Entrepreneurship & Innovation Committee. Tohami is on a mission to transform the state of unfulfilled employees worldwide!

-

Mohannad Alshibani, Pharm.D, BCPS Dr. Alshibani is an Assistant Professor at the Pharmacy Practice Department at King Abduaziz University in Jeddah, Saudi Arabia. He is the deputy of Pharmacy Residency program at King Abdulaziz University Hospoital in Jeddah, Saudi Arabia. Also, he is a senior Internal Medicine Clinical Pharmacist at King Abdulaziz University Hospital. Dr. Alshibani received a Doctor of Pharmacy degree from King Abdulaziz University in 2009. He completed a PGY1 Pharmacy Practice Residency at Northwest Medical Center in Tucson, Arizona in 2015 and a PGY2 Residency in Internal Medicine at Banner - University Medical Center in Tucson, Arizona in 2016. In addition, he completed a Postdoctoral Fellowship in Internal Medicine at University of Arizona in 2018. His areas of interest include internal medicine, research and academia.

Mohsin al balushi,Pharmacist in pharmaceutical care department in directorate general of medical supplies (DGMS). Graduated from Oman pharmacy institute in 2010. Since graduation, he has worked in different sections of medical stores. In 2014, he went to UK for master of pharmacy degree in Robert Gordon University. In 2019, he joined pharmaceutical care department. During this year, he took part in many activities. Such as, setting new policies and guidelines and ensuring proper implementation of them in health institutions. Moreover, organizing pharmaceutical events and designing posters and brochures to highlight pharmaceutical care services. He is also an active organizing member of pharmaceutical care conference

Mona Almanasef is an assistant professor in the Clinical Pharmacy Department at King Khalid University, Saudi Arabia. She undertook her first degree in pharmaceutical sciences at King Saud University in Saudi Arabia (2009). She completed her master’s degree in Clinical Pharmacy, International Practice and Policy at UCL School of Pharmacy in 2012 followed by a PhD in Pharmacy Practice and Policy in January 2018. Her doctoral research looked at the feasibility, acceptability and effectiveness of the “flipped classroom” instructional model on MPharm students in two pharmacy schools in the UK. Dr. Mona is an Associate Fellow of the Higher Education Academy in the UK. Her research interests include pharmacy education and active learning methods.

Monira Alwhaibi, MS, Ph.D., is Assistant Professor at the Clinical Pharmacy Department, King Saud University. She received her Ph.D. degree in 2016 from West Virginia University, United States. Dr. Alwhaibi’s primary areas of research interests include health services research, with particular emphasis on pharmacoepidemiology, medication use, looking at issues of prevalence, drugs safety, mental health, oncology, cost-analysis of drugs in healthcare systems, and complementary and alternative medicine use. Dr.Alwhaibi had more than twenty publications on these areas. Dr.Alwhaibi is proficient in handling large healthcare data (Claims Databases, EMR /electronic health data, clinical data, etc.). Dr.Alwhaibi is also skilled in using SQL, Statistical Analysis Software (SAS), and STATA.

Musaed Alkholief earned his Ph.D. in 2015 from Massachusetts College of Pharmacy and Health Sciences University, USA. Following his return to Saudi Arabia, he was appointed as an Assistant Professor at the College of Pharmacy, King Saud University. Currently, Dr. Alkholief is the director of the project management office (PMO) at the college. Also, Dr. Alkholief heads the Nanobiotechnology unit that carries out research in multiple areas, including his area of interest, cancer drug delivery and drug targeting.

Qualification: Bachelor (Pharmacy) University of Nizwa 2011 Training History MED REC workshop DGMS, MOH Research methodology UN, DGMS, MOH, Clarck ship training ( Advanced pharmact practice 1,2) USA, Clinical attachment SQUH Clinical attachment in Medicine department, ICU, CCU, N, Nephrology department. Nizwa hospital Statistic course SQUH patient safety (poly pharmacy) Ministry Of Health

-

-

Olaf Klungel is Professor of Pharmacoepidemiologic Methods and head of the division of Pharmacoepidemiology & Clinical Pharmacology at Utrecht University, the Netherlands. where he leads a multidisciplinary team performing research on several epidemiological, therapeutic, and policy aspects of drug use with the goal to contribute to a better benefit-risk ratio of therapeutics for individual patients and for public health in general. He was trained as a pharmacist and epidemiologist. His main research area is the development, improvement and evaluation of innovative methods of observational drug research with applications in the post-registration phase of drug development. He is President-Elect of the International Society for Pharmacoepidemiology (ISPE) and elected steering group member of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). He was chair of the scientific program committee of the International Conference of Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Prague 2018. Prof. Klungel is member of the executive committee of the European Program in Pharmacoepidemiology & Pharmacovigilance (Eu2P, Director of Benefit/Risk Assessment domain), and he is principal investigator of the EU Pharmacoepidemiology & Pharmacovigilance Research Network (EU PE&PV, formerly IMI-PROTECT). The EU PE&PV network conducts research on safety and effectiveness of medicines for the European Medicines Agency (EMA). Selected research findings on benefits and harms of medicines include the impact of genetic variants in the renin-angiotensin and salt-sensitivity system on the risk of type 2 diabetes mellitus and myocardial infarction associated with the use of thiazide diuretics and ACE inhibitors, the increased risk of autoimmune diseases such as rheumatoid arthritis (Ann Rheum Dis 2011, PLoS One 2018) and lupus-like syndrome (Semin Arthritis Rheum 2011, Ann Rheum Dis 2017) associated with the use of statins and increased risk of nephrotic syndrome associated with the use of NSAIDs (Clin J Am Soc Nephrol 2019). Furthermore, Prof. Klungel teaches pharmacoepidemiology and pharmacotherapy to medical and pharmacy students. He is (co-)author of over 300 papers in peer reviewed journals, book chapters and research reports. His H-index is 43.

-

-

Patrick Kilbride is senior vice president of the Global Innovation Policy Center (GIPC) at the U.S. Chamber of Commerce. There he oversees the center’s domestic, multilateral, and international programs and leads GIPC’s policy work to promote intellectual property-driven innovation and creativity. Previously, Kilbride was executive director of Americas Strategic Policy Initiatives and executive vice president of the Association of American Chambers of Commerce in Latin America and the Caribbean (AACCLA) in the Chamber’s International Division. Kilbride served in the Executive Office of the President during the George W. Bush administration as deputy assistant U.S. Trade Representative (USTR) for intergovernmental affairs & public liaison. At USTR, he worked with state and local officials, business organizations, and non-governmental organizations to advance the president’s trade policy agenda. Earlier in his career, Kilbride held various private sector roles advocating on behalf of business for rule of law and market openings through free trade agreements. He is a graduate of The George Washington University and resides with his family in Alexandria, Virginia.

Peter Pitts is President of the Center for Medicine in the Public Interest and Chief Regulatory Officer at Adherent Health Strategies. A former member of the United States Senior Executive Service, Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce and is a Special Government Employee (SGE) consultant to the FDA’s Risk Communications Advisory Committee. He is also a Adjunct Scholar at the Washington Policy Center. Specific areas of global policy expertise include FDA policy and process, healthcare technology assessment and reimbursement issues, biosimilar development, Rx-to-OTC switching, risk management plans, GMP policies, pharmacy education programs, drug safety, DTC/ItP, Critical Path, personalized medicine, clinical trial transparency, IP protection, FDA reform, drug importation, counterfeiting, genetically modified food issues, food safety and security, recalls, nutritional labeling.

Phil Cooper has spent his entire career in product manufacturing starting in the food and beverage sectors and more recently in the pharmaceutical sector, first as an engineer with Brooke Bond and Kraft Foods then in both technical and commercial roles with some well respected and well known companies who supply equipment to manufacturers of many of the brand names we all recognise. He has worked in product development and machinery sales specialising in bringing new equipment and technologies to different areas of pharmaceutical, food and beverage manufacturing and facilitating the ‘cross over’ of technologies between sectors. Starting with Heuft as Business Development Manager – Food followed by some time as Sales and Marketing Manager UK and Ireland he is now Business Development Manager - Pharma. Seeing things from both the end user persepective as well as the equipment supplier persepctive enables Phil to understand the need for technical and commercial alignment to meet the end user requirements and sometimes take them beyond what they know is possible.

Experience • 1996-1998 Diploma in Pharmaceutical Sciences (Kuwait), first class • 2004-2005 Mpharm in John Moores University (UK), second lower • 2010-2011 Master in Pharmaceutical services and medicines control Bradford University (UK), merit • 2013 International Diabetes Federation as diabetic patient educator • 2018 Starting PhD program in diabetes health economics Working Forced Armed Hospital, Kuwait • 12/12/1998 Start my job in Jaber Al-Ahmed Army Hospital • 1998-2004 Worked as pharmacist technician • 2009-2011 Worked as pharmacist • 2012-2014 Worked as the head of pharmacy department • 2015- Working as senior pharmacist in-charge in the medical store of the Ministry of Defense Communication • Teamwork: Participate in Kuwait Pharmacist Institution • Self motivation: Diabetic patient educator

Dr. Sindelar is a Professor and Former Dean, Faculty of Pharmaceutical Sciences. Dr. Sindelar is also an elected fellow of the Canadian Academy of Health Sciences, and elected fellow of the International Pharmaceutical Federation (FIP), Chair of the Global Pharmacy Observatory Advisory Board of FIP, and Member of the External Advisory Board, Trinity College Dublin, School of Pharmacy and Pharmaceutical Sciences. In addition, he previously was appointed Vice President of Innovation, Research & Academic Affairs at Providence Health Care, President of the Providence Health Care Research Institute and Associate Dean Research in the UBC Faculty of Medicine (2013-2016). In these various roles, Dr. Sindelar has and continues to contribute to research, health policy, team-building, international partnerships, as well as strategic innovations. His research expertise is in medicinal chemistry, computer-aided drug discovery, and pharmaceutical biotechnology. Dr. Sindelar is the recipient of several School and University-wide teaching honors during his academic career. He has co-edited 5 editions of the highly successful textbook entitled “Pharmaceutical Biotechnology: Fundamentals and Applications.” While serving as Dean at UBC, he was instrumental in the fundraising, design and building of a new 250,000 sqft building that has won numerous awards for design, functionality and innovation. He has taught in the professional and graduate curriculum and serves on scientific advisory and editorial boards. In addition, he is a founder of the Centre for Drug Research and Development (formerly CDRD, now called adMare BioInnovations), a national not-for-profit drug development and commercialization centre that provides expertise and infrastructure to enable researchers to advance promising early-stage drug candidates.

Dr. Rouba Eid experience in the region started in 2013 when she joined the industry after a career path at the US FDA. Her experience since then focuses on pharmacovigilance systems setup, merges/integrations of PV systems and PV operation in the Turkey, Middle East and Africa. Dr. Eid received her Bachelor of Pharmacy degree from the Massachusetts College of Pharmacy in Boston, USA and her Doctorate in Clinical Pharmacy from Midwestern University in Illinois, USA. She obtained a Diploma in Epidemiology from the University of Bordeaux, France and completed a fellowship in the US FDA, Office of Compliance in Washington DC where she subsequently worked till 2013 .Prior to this, Dr. Eid served as the Associate Dean and Founder of the School of Pharmacy at the Lebanese International University of Beirut where she obtained 10 years’ experience in higher education management, training and curriculum development.

EXPERIENCE PHARMACIST (HEALTHCARE) • 5 years in Government Sector • 5 years in Private Sector GENERAL MANAGER • Bellazone company for public commerce. EDUCATION BACHELOR OF PHARMACY • Kuwait University in 2008 MASTER OF BUSINESS ADMINISTRATION • Dutch Maastricht college (pending discussion of the thesis).

My name is Saleh Alzahrani, working as supply chain director in king Fahad Armed Forces Hospital in Jeddah, I’m holding a master degree from Leeds university in pharmaceutical engineering. My carrier has been shifted from pharmacy practices to supply chain Leadership. I’m a team leader for more than 120 members. I’ve led many projects to optimize the whole supply chain operations. Very interested in digitalization and health care transformation.

Manager Quality pharmaceutical care services in King Abdulaziz medical city in Riyadh, and CBAHI Medication Management Surveyor since 2014-till now, hold master degree in pharmaceutical science from king Saud university 2015, and master degree in total quality management from The Arab Academy for Science and Technology and Maritime Transport, Alexandria, Egypt 2006, Also Certified Patient Safety Officer ( CPSO ), AIHQ since April 2015, Lecturer at the College of Pharmacy, King Saud bin Abdulaziz University for Health Science with lots of Courses inpatient and medication Safety and quality. Certified CPHQ ( score (106) ) September 2016. Lean Six Sigma Yellow Belt Certified February 18th -19th, 2015, Lean Six Sigma Green Certified February 20 -22, 2015. Member in Medication Safety Program in National Guard.

HE Salem Bin Lahej is the Director of the Healthcare Fund Office at the Dubai Health Authority (DHA), where he has played an integral role in establishing the Patient Assistance Program and Patient Assistance Program, a pioneering initiative, spearheaded by DHA and their strategic partner. H.E Bin Lahej has a far-reaching and distinguished background in charitable causes. He sat on the Board of Directors of the Dar al Ber Society, a leading charity in the United Arab Emirates (UAE) that provides educational, cultural, medical, and humanitarian assistance to vulnerable populations. He also sits on the Board of Trustees of the Emirates Science Club, Culture and Science Symposium. Prior to joining the DHA in 1994, HE Bin Lahej spent over a decade serving the Ministry of Education of the United Arab Emirates, where he worked as a Social Worker and supported the establishment of infrastructure for social services and student activities. He holds a bachelor’s degree from the United Arab Emirates University. Other than being director of healthcare fund office, He is Member of the Research Ethics Council, Member of the Board of Directors in Dubai appreciation award for community service and head of the pink ride

Samuel Razzak has started his career as a product development manager at Bayer CropScience AG, while he was on dual studies at Hannover University. After graduation in biotchnology, Samuel Razzak applied for the studying pharma management at University of Leipzig in Germany. Samuel Razzak worked as a sales manager for AnalytikJena AG, and during this time he was involved in the development of automated DNA and RNA extraction products. Starting with Heuft in 2018, Samuel Razzak is now an international sales manager in the pharma division, and he is also involved in the business development at HEUFT SYSTEMTECHNIK GMBH. Seeing things from both the end user persepective as well as the equipment supplier persepctive enables Samuel to understand the need for technical and commercial alignment to meet the end user requirements and sometimes take them beyond what they know is possible.

Bachelor of pharmacy, Kuwait university, faculty of pharmacy 2010-2015 GPA: 2.58 Working experience: Ministry of health of Kuwait: - Completed rotation of eight months: Two months: polyclinic in bader alnafeisi polyclinic Six months: al sabah area - One year at Alrawda polyclinic - Current working place: chest hospital Kuwait university: Completed working as a teacher assistant for third and fourth year pharmacy students with Kuwait university pharmacy practice department (courses 2016/2017)

-

Stuart T. Haines, Pharm.D., BCPS, BCACP, BC-ADM is Professor (with tenure), Department of Pharmacy Practice and Director, Division of Pharmacy Professional Development at the University of Mississippi School of Pharmacy and previously Professor and Vice Chair, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy. Dr. Haines is Immediate-Past Chair of the Council of Faculties in the American Association of Colleges of Pharmacy (AACP), a Past-President of the American College of Clinical Pharmacy (ACCP), Chaired the AACP 2015-2016 Academic Affairs Committee that developed the Core Entrustable Professional Activity (EPA) statements for new pharmacy graduates, and was a member of the Task Force that petitioned the Board of Pharmacy Specialties (BPS) to recognize ambulatory care pharmacy practice as a specialty. Dr. Haines is the Editor-in-Chief of iForumRx.org, an online journal club for ambulatory care pharmacy specialists, an Associate Editor for the Journal of the American College of Clinical Pharmacy, and an Editor for the textbook Pharmacotherapy: A Pathophysiologic Approach. He has served as a Scientific Editor for the journal Pharmacotherapy and on numerous editorial boards including American Journal of Pharmaceutical Education (AJPE), Annals of Pharmacotherapy, Current Medical Research and Opinion (CMRO), the Journal of the American Pharmacists Association (JAPhA), American Journal of Health-System Pharmacy (AJHP), and the Pharmacists’/Prescribers’ Letter. He has authored more than 120 scholarly papers and book chapters regarding diabetes, cardiovascular disease, ambulatory care pharmacy practice models, and instructional methods. Dr. Haines earned his Bachelor of Science in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Doctor of Pharmacy from the University of Texas at Austin. He completed a Pharmacy Practice Residency at the Brigham and Women’s Hospital in Boston as well as an Ambulatory Care Pharmacy Practice Residency at the University of Texas Health Science Center in San Antonio. He is board certified in Ambulatory Care Pharmacy Practice (BCACP), Pharmacotherapy (BCPS), and Advanced Diabetes Management (BC-ADM). Dr. Haines is a fellow in the American College of Clinical Pharmacy (FCCP), American Society of Health-System Pharmacists (FASHP), and the American Pharmacists Association (FAPhA). Dr. Haines is a Distinguished Practitioner and Fellow in the National Academies of Practice (FNAP) and received the Ambulatory Care Achievement Award from the ACCP Ambulatory Care Practice and Research Network (2009) as well as the Distinguished Achievement Award in Ambulatory and Community Practice from APhA (2010). Lastly, he was the recipient of the ACCP Educator (2010) and Robert M. Elenbaas Service (2016) Awards.

Dr. Sukainah Al Alshaikh is a researcher on cerebrovascular disorders with a particular focus on stroke prevention. She has obtained a Bachelor in Pharmaceutical Sciences from King Saud University then got her MSc in Clinical Pharmacy from the University of Strathclyde and obtained a PhD in Cardiovascular Sciences from the University of Glasgow in Scotland, the UK. Dr. Sukainah has presented her work in International Conferences in the United Kingdom, United States, France, Turkey and the United Arab Emirates. She is currently the Head of Pharmacy Department & Assistant Professor of Clinical Pharmacy at Mohammed Al-mana College for Medical Sciences in AlKhobar, Saudi Arabia.

Dr. Tom Johnson received his Doctor of Pharmacy degree from North Dakota State University and completed his Pharmacy Residency at St. Alexius Medical Center and NDSU in Bismarck, North Dakota. He earned his Master of Business Administration degree from the University of Sioux Falls in 2009. From1998 through 2010, he held a shared faculty appointment with South Dakota State University and Avera McKennan Hospital in the specialty of Critical Care. He is currently the Assistant Vice President of Hospital Pharmacy at Avera Health based in Sioux Falls, South Dakota. Dr. Johnson is Board Certified in both Critical Care and Pharmacotherapy. He is also a member of many interdisciplinary and pharmacy professional organizations including the Society of Critical Care Medicine (SCCM), the American College of Clinical Pharmacy (ACCP), the American College of Healthcare Executives (ACHE), and the American Society of Health-System Pharmacists (ASHP). He has served ASHP as a Board Member (2011-2014), and then the Treasurer (2016-2019), and currently serves as President-Elect. He is a past-president of the South Dakota Society of Health-System Pharmacists and was awarded the SDSHP Pharmacist of the Year Award in 2005. In 2009, he received recognition as a Fellow of the American Society of Health-System Pharmacists and in 2012 as a Fellow of the American College of Critical Care Medicine.

Thuraya bumozah is a clinical pharmacist at the Maternity and children hospital (MCH), Alhasa-KSA. Dr.Thuraya earned her Bachelor’s degree in Pharmaceutical Sciences with honors from King Saud University in 2004 and her Master of Clinical Pharmacy from College of Pharmacy, The University of Queensland, Australia in 2010. Dr.Thuraya has more than 14 years’ experience working at Ministry Of Heath as hospital pharmacist; seven years of them as a clinical pharmacist in the Pediatric intensive care unit. In December 2012 she was appointed to be the Chairwoman of scientific Committee in ALhasa Pharmacy Club (APC)-Saudi Pharmaceutical Society (SPS). Thuraya participated in a large number of local scientific meetings as a speaker or organizer. She coordinated and supervised clinical pharmacy students' training programs at the hospitals where she participated in the preparation of continuing educational program, for pharmacy staff, and staff development and was appointed with several administrative pharmacy positions as a supervisor. Other areas of interest include quality improvement and medication safety.

Wafa Albalushi received her Master of pharmacy degree from Robert Gordon University in United Kingdom in June 2015. She received her pharmacy diploma from Oman in January 2008. In 2015 she joined the department of pharmacy atBarka polyclinic and serves as pharmacist for almost 2 years. Joined Nakhal health center and worked as pharmacist since 2016 till now. She has made numerous presentations to healthcare staff at hospital level and national level focusing in Pharmaceutical care. Aside from Wafa’sexperience in different filed of pharmaceutical care, she is dedicatedin improving patient’s safety with focus on medication use process she become one of smart pharmacist in Oman after applying Smart pharmacy program in 2017. She is theleader of pharmaceutical care at the Nakhal health center, which aim to improve health care awareness about medication safety and quality.Member of the Pharmaceutical Society of Oman, Member of scientific committee of the Omani Pharmaceutical Society, Member and trainer of the Smart pharmacy program in Oman.

Wahida Abdelaziz Mohammad Jassem is the Head of the Friends of Arthritis Patients Association, one of the health support Associations of the Health Promotion Department at the Supreme Council for Family Affairs in Sharjah with 11 years of specialized experience raising awareness and provide support for patients with arthritis. Wahida is a Project Manager of the “Skills Development Department”, a member of the Emirates School Sports Federation, and the national coordinator of the Arab Reading Challenge project. Advancing through a serious of 5 promotions since then in the educational sector, Wahida worked as a Curator of Learning Resources Centre in 4 different schools, Head of the Learning Resources Unit in Sharjah Educational Zone, Head of the Educational Activities and Competitions Unit in Sharjah Educational Zone over 4 years, worked in Ministry of Education at the Activity Sector, and Director of projects in care and activities sector for 2 years. She has been an active volunteer in the Society of Friends of Arthritis Patients Association in 2009 and supervised organizing the activities and events that achieve the vision of Her Highness Shaikha Jawaher Bent Mohammed Al Qassimi, Chairman of the Supreme Council for the Family Honorary President of the Association, which focuses on spreading awareness of joint diseases and provides support for joint diseases and knows all members of society about joint diseases and methods Prevention and inviting the community to exercise. Wahida received the Best Educational Project Award, Sharjah Award for Educational Excellence Category Secretary of the Learning Resources Center, her recent honor is the National General Coordinator Award for Reading was on 2018. Wahida earned her BS. degree with an Administrative and Political Sciences major and Parliamentary Work Diploma in 2018

Education: German University In Cairo GUC (class 2009 ) Bachelor of science in Pharmacy and Biotechnology. Cairo International School Thanawiya Amma School  9 A-C GCSE equivalents. Incl. Arabic, English, Mathematics and Double Science. Clinical Pharmacy Professional Diploma (Pharmacotherpy) Experience Oman Medical College: June-September 2013 Lab instructor. Khoula Hospital:: 2013-2019 Pharmacy Department

Dr. Yoshimichi Sai is Professor and Director of Department of Hospital Pharmacy, Kanazawa University. He received his B.S. (1989) in Pharmaceutics and his M.S. (1991) and Ph.D. (1994) in Biochemistry from the Kanazawa University. He is a faculty member of Graduate School of Medical Sciences, Kanazawa University. He has studied abroad for two years with Dr. Irwin M. Arias as a postdoctoral fellow at the Tufts University School of Medicine (1997-1999). Prof. Sai is the (co)-author of 169 research articles, 18 reviews, 19 book chapter, 50 invited lectures and more than 540 abstracts presented domestic and international conferences. He was awarded the Young Investigator Award, Japanese Society for the Study of Xenobiotics in 2004 and the Young Investigator Award 2002 of the Pharmaceutical Society of Japan, Hokuriku branch. His current research interests include: i) molecular biopharmaceutical study on metabolic enzymes and drug transporters as a molecular determinant of inter and intra-individual variability of drug efficacy, toxicity and disposition, ii) clinical pharmacokinetic study on monitoring and avoidance of adverse effect of drugs, iii) development of administration planning for proper use of drug, individualized medicine to improve QOL of patients. He is the current Board Director of the Japan Pharmaceutical Association, the Japanese Society of Hospital Pharmacists, and the Japanese Society of Pharmaceutical Health Care and Sciences.

-

Dr Zahra AL Qamariat is a Senior Clinical Pharmacist graduated from the School of Pharmacy University of London with a Master degree in Clinical Pharmacy International Practice and Policy. Then, she joined the Saudi Ministry of health and has been working as Senior Clinical Pharmacist at Dammam Medical Complex mainly in Infectious Disease and Intensive Care and a supervisor for clinical pharmacy services. Recently, Dr Zahra is the Chairperson of Antimicrobial Stewardship Committee in Dammam Medical Complex since May 2019. Also, she is the Chairperson of Clinical Pharmacy Committee in Eastern Health and the Rapporteur of Antimicrobial Committee, Eastern Health, Saudi Arabia since January 2017. Dr AL Qamariat has successfully complete courses in research from Harvard Medical School and King Faisal Specialist Hospital and Research. She is certified antimicrobial stewardship pharmacist from the American Society of Infectious Disease Pharmacist, and Professional Infection Control and Prevention from the American university of Ras Al Khaimah. Certified Anticoagulation Therapy Pharmacist by University of Florida.